Details

Autor(en) / Beteiligte

• Aldaba-Muruato, Liseth Rubi
• Sánchez-Barbosa, Sandra
• Rodríguez-Purata, Víctor Hugo
• Cabrera-Cruz, Georgina
• Rosales-Domínguez, Estefany
• Martínez-Valentín, Daniela
• Alarcón-López, Yoshio Aldo
• Aguirre-Vidal, Pablo
• Hernández-Serda, Manuel Alejandro
• Cárdenas-Granados, Luis Alfonso
• Vázquez-Valadez, Víctor Hugo
• Angeles, Enrique
• Macías-Pérez, José Roberto

Titel

IIn Vivo/I and IIn Silico/I Studies of the Hepatoprotective Activity of ITert/I-Butylhydroquinone

Ist Teil von

• International journal of molecular sciences, 2023-12, Vol.25 (1)

Ort / Verlag

MDPI AG

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Tert-butylhydroquinone (TBHQ) is a synthetic food antioxidant with biological activities, but little is known about its pharmacological benefits in liver disease. Therefore, this work aimed to evaluate TBHQ during acute liver damage induced by CCl[sub.4] (24 h) or BDL (48 h) in Wistar rats. It was found that pretreatment with TBHQ prevents 50% of mortality induced by a lethal dose of CCl[sub.4] (4 g/kg, i.p.), and 80% of BDL+TBHQ rats survived, while only 50% of the BDL group survived. Serum markers of liver damage and macroscopic and microscopic (H&E staining) observations suggest that TBHQ protects from both hepatocellular necrosis caused by the sublethal dose of CCl[sub.4] (1.6 g/kg, i.p.), as well as necrosis/ductal proliferation caused by BDL. Additionally, online databases identified 49 potential protein targets for TBHQ. Finally, a biological target candidate (Keap1) was evaluated in a proof-of-concept in silico molecular docking assay, resulting in an interaction energy of −5.5491 kcal/mol, which was higher than RA839 and lower than monoethyl fumarate (compounds known to bind to Keap1). These findings suggest that TBHQ increases the survival of animals subjected to CCl[sub.4] intoxication or BDL, presumably by reducing hepatocellular damage, probably due to the interaction of TBHQ with Keap1.